Skip to content
HIGHLIFE MEDICAL
Menu
  • Home
  • About Us
    • Board of Directors
  • Mitral Valve Insufficiency
  • Technology
  • Healthcare Professionals
    • Physician Feedback
    • Publications
  • News
  • Contact

Tag: TMVR

Corporate

May 9, 2018 – HighLife appoints Dr. Martin Rothman as independent member of the board

HighLife SAS, a medtech company focused on the development of a unique trans- catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment …

Clinicals

Sep. 22, 2017 – HighLife Successfully Initiates its Clinical Study in Europe

First 3 activated clinical centers in France enroll patients HighLife SAS announced today the start of its European clinical study with the enrollment of the first 3 patients at major …

Clinicals

Sep. 14, 2016 – HighLife successfully initiates its clinical feasibility phase

HighLife SAS announced today the successful treatment of 5 consecutive patients in its early feasibility clinical phase. The first three cases were carried out in Kiev (Ukraine) in the adult …

Copyright © 2022 HIGHLIFE MEDICAL – OnePress theme by FameThemes